SpectraScience to Present at OneMedForum on January 11, 2012
(firmenpresse) - SAN DIEGO, CA -- (Marketwire) -- 01/09/12 -- SpectraScience, Inc. (OTCQB: SCIE) (PINKSHEETS: SCIE), a San Diego based medical device company, today announced that President and Chief Executive Officer Michael Oliver will present to investors and analysts at the OneMedForum in San Francisco at the Sir Francis Drake Hotel. Mr. Oliver is scheduled to present at 10:30 a.m. Pacific on Wednesday, January 11, 2012. Held during the largest gathering of healthcare financiers and executives, the conference has grown in size and stature and is now a central meeting point for those involved in building the future of health and medicine.
Founded in 2008, OneMedForum is a biannual event held in San Francisco and in New York. OneMedForum creates a platform for emerging companies to connect with strategic partners and investors. For more about OneMedForum SF 2012 visit .
SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets light-based analysis systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT Optical Biopsy System uses light to optically diagnose tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.
Contact:
SpectraScience, Inc.
Jim Dorst
Chief Financial Officer
(858) 405-9933
Investor Relations
LHA
Don Markley
(310) 691-7100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.01.2012 - 13:56 Uhr
Sprache: Deutsch
News-ID 102087
Anzahl Zeichen: 0
contact information:
Town:
SAN DIEGO, CA
Kategorie:
Commercial & Investment Banking
Diese Pressemitteilung wurde bisher 143 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"SpectraScience to Present at OneMedForum on January 11, 2012"
steht unter der journalistisch-redaktionellen Verantwortung von
SpectraScience, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
